Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jan-24 4:11 PM View:  | Mersana Therapeutics, Inc. (MRSN) | 02-Jan-24 | Grant | 8,810 | -- | -- | 1% 589.48K to 598.29K | |
| 04-Oct-23 4:26 PM View: | Mersana Therapeutics, Inc. (MRSN) | 02-Oct-23 | Grant | 15,873 | -- | -- | 3% 573.61K to 589.48K | |
| 06-Jul-23 4:18 PM View: | Mersana Therapeutics, Inc. (MRSN) | 03-Jul-23 | Grant | 6,079 | -- | -- | 1% 567.53K to 573.61K | |
| 13-Jun-23 4:47 PM View: | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 3,100 | -- | -- | 8% 40.7K to 43.8K | |
| 12-Jun-23 10:00 PM View: | Mersana Therapeutics, Inc. (MRSN) | 08-Jun-23 | Grant | 14,467 | -- | -- | 3% 553.06K to 567.53K | |
| 05-Apr-23 5:14 PM View: | Mersana Therapeutics, Inc. (MRSN) | 03-Apr-23 | Grant | 4,866 | -- | -- | < 1% 548.19K to 553.06K | |
| 17-Nov-22 4:07 PM View: | Ardelyx, Inc. (ARDX) | 17-Nov-22 | Purchase | 567,000 | $1.76 | $1,000,640.00 | 95% 599.76K to 1.17M | |
| 16-Aug-22 6:59 PM View: | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 8,994 | -- | -- | (3%) 331.45K to 322.45K | |
| 16-Aug-22 6:59 PM View: | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition (change in control) | 215,494 | -- | -- | (67%) 322.45K to 106.96K | |
| 16-Aug-22 6:59 PM View: | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition (change in control) | 106,959 | -- | -- | (100%) 106.96K to 0 | |
| 05-Jul-22 5:06 PM View: | Epizyme, Inc. (EPZM) | 30-Jun-22 | Grant | 16,156 | $1.47 | $23,749.30 | 5% 315.29K to 331.45K | |
| 21-Jun-22 8:49 PM View: | Novavax, Inc. (NVAX) | 17-Jun-22 | Option Exercise | 700 | -- | -- | 2% 40.0K to 40.7K | |
| 21-Jun-22 4:51 PM View: | Ardelyx, Inc. (ARDX) | 15-Jun-22 | Grant | 182,481 | -- | -- | 44% 417.28K to 599.76K | |
| 19-May-22 4:26 PM View: | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 3% 306.3K to 315.29K | |
| 01-Apr-22 5:30 PM View: | Epizyme, Inc. (EPZM) | 31-Mar-22 | Grant | 20,653 | $1.15 | $23,750.90 | 7% 285.64K to 306.3K | |
| 23-Feb-22 7:12 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-22 | Purchase | 35,257 | $1.46 | $51,475.20 | 18% 193.97K to 229.22K | |
| 23-Feb-22 7:12 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Feb-22 | Purchase | 65,817 | $1.56 | $102,675.00 | 51% 128.15K to 193.97K | |
| 23-Feb-22 7:12 PM View: | Enliven Therapeutics, Inc. (ELVN) | 18-Feb-22 | Private Purchase | 50,398 | $1.30 | $65,517.40 | 65% 77.75K to 128.15K | |
| 17-Feb-22 7:21 PM View: | Enliven Therapeutics, Inc. (ELVN) | 17-Feb-22 | Purchase | 14,595 | $1.17 | $17,076.10 | 23% 63.16K to 77.75K | |
| 17-Feb-22 7:21 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Feb-22 | Purchase | 11,779 | $1.20 | $14,134.80 | 23% 51.38K to 63.16K | |
| 17-Feb-22 7:21 PM View: | Enliven Therapeutics, Inc. (ELVN) | 15-Feb-22 | Private Purchase | 19,552 | $1.20 | $23,462.40 | 61% 31.83K to 51.38K | |
| 14-Feb-22 5:02 PM View: | Enliven Therapeutics, Inc. (ELVN) | 14-Feb-22 | Purchase | 8,500 | $1.18 | $10,030.00 | 36% 23.33K to 31.83K | |
| 14-Feb-22 5:02 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Feb-22 | Purchase | 14,573 | $1.23 | $17,924.80 | 166% 8.75K to 23.33K | |
| 14-Feb-22 5:02 PM View: | Enliven Therapeutics, Inc. (ELVN) | 10-Feb-22 | Private Purchase | 8,753 | $1.29 | $11,291.40 | 100% 0 to 8.75K | |
| 04-Jan-22 4:20 PM View: | Epizyme, Inc. (EPZM) | 31-Dec-21 | Grant | 9,500 | $2.50 | $23,750.00 | 3% 276.14K to 285.64K | 14% |
| 01-Oct-21 4:30 PM View: | Epizyme, Inc. (EPZM) | 30-Sep-21 | Grant | 4,640 | $5.12 | $23,756.80 | 2% 271.5K to 276.14K | < 1% |
| 24-Sep-21 10:00 PM View: | Novavax, Inc. (NVAX) | 23-Sep-21 | Market Sale | 24,961 | $252.90 | $6,312,620.00 | (38%) 64.96K to 40.0K | 2% |
| 01-Jul-21 4:15 PM View: | Epizyme, Inc. (EPZM) | 30-Jun-21 | Grant | 2,858 | $8.31 | $23,750.00 | 1% 268.65K to 271.5K | 0% |
| 15-Jun-21 4:35 PM View: | Epizyme, Inc. (EPZM) | 11-Jun-21 | Grant | 8,060 | -- | -- | 3% 260.59K to 268.65K | |
| 01-Apr-21 7:00 PM View: | Epizyme, Inc. (EPZM) | 31-Mar-21 | Grant | 2,727 | $8.71 | $23,752.20 | 1% 257.86K to 260.59K | 0% |
| 29-Mar-21 4:30 PM View: | Epizyme, Inc. (EPZM) | 26-Mar-21 | Market Purchase | 34,486 | $7.97 | $274,817.00 | 15% 223.37K to 257.86K | (< 1%) |
| 29-Mar-21 4:30 PM View: | Epizyme, Inc. (EPZM) | 25-Mar-21 | Market Purchase | 28,231 | $7.98 | $225,283.00 | 14% 195.14K to 223.37K | (1%) |
| 05-Jan-21 8:15 AM View: | Epizyme, Inc. (EPZM) | 31-Dec-20 | Grant | 2,158 | $10.86 | $23,435.90 | 1% 192.98K to 195.14K | (1%) |
| 15-Dec-20 4:15 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Dec-20 | Acquisition (other) | 1,582 | -- | -- | < 1% 546.61K to 548.19K | |
| 10-Dec-20 6:22 PM View: | Ardelyx, Inc. (ARDX) | 10-Dec-20 | Market Purchase | 170,000 | $5.89 | $1,000,840.00 | 69% 247.28K to 417.28K | 19% |
| 03-Dec-20 7:01 AM View: | Mersana Therapeutics, Inc. (MRSN) | 01-Dec-20 | Acquisition (other) | 1,613 | -- | -- | < 1% 545.0K to 546.61K | |
| 12-Nov-20 4:30 PM View: | Mersana Therapeutics, Inc. (MRSN) | 09-Nov-20 | Acquisition (other) | 1,608 | -- | -- | < 1% 543.39K to 545.0K | |
| 01-Oct-20 4:58 PM View: | Epizyme, Inc. (EPZM) | 30-Sep-20 | Grant | 1,965 | $11.93 | $23,442.50 | 1% 191.02K to 192.98K | (1%) |
| 12-Nov-20 4:30 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Sep-20 | Acquisition (other) | 1,602 | -- | -- | < 1% 541.79K to 543.39K | |
| 01-Jul-20 5:04 PM View: | Epizyme, Inc. (EPZM) | 30-Jun-20 | Grant | 1,459 | $16.06 | $23,431.50 | < 1% 189.56K to 191.02K | (26%) |
| 26-Jun-20 7:12 PM View: | Epizyme, Inc. (EPZM) | 26-Jun-20 | Market Purchase | 62,019 | $16.03 | $994,165.00 | 49% 127.54K to 189.56K | (26%) |
| 26-Jun-20 4:19 PM View: | Ardelyx, Inc. (ARDX) | 25-Jun-20 | Market Purchase | 68,373 | $6.96 | $476,040.00 | 38% 178.91K to 247.28K | 1% |
| 26-Jun-20 4:19 PM View: | Ardelyx, Inc. (ARDX) | 24-Jun-20 | Market Purchase | 72,598 | $6.75 | $489,862.00 | 68% 106.31K to 178.91K | 4% |
| 24-Jun-20 6:49 PM View: | Ardelyx, Inc. (ARDX) | 22-Jun-20 | Market Purchase | 4,673 | $6.75 | $31,525.00 | 5% 101.64K to 106.31K | 4% |
| 22-Jun-20 7:39 PM View: | Epizyme, Inc. (EPZM) | 18-Jun-20 | Acquisition (other) | 67,662 | -- | -- | 113% 59.88K to 127.54K | |
| 11-Jun-20 7:53 PM View: | Ardelyx, Inc. (ARDX) | 10-Jun-20 | Acquisition (other) | 1,079 | -- | -- | 1% 100.56K to 101.64K | |
| 11-Jun-20 7:53 PM View: | Ardelyx, Inc. (ARDX) | 09-Jun-20 | Grant | 12,995 | -- | -- | 15% 87.57K to 100.56K | |
| 13-Apr-20 9:08 PM View: | Mersana Therapeutics, Inc. (MRSN) | 09-Apr-20 | Acquisition (other) | 3,190 | -- | -- | < 1% 538.6K to 541.79K | |
| 09-Apr-20 3:31 PM View: | Mersana Therapeutics, Inc. (MRSN) | 07-Apr-20 | Market Purchase | 538,599 | $5.59 | $3,010,770.00 | 100% 0 to 538.6K | 379% |
| 02-Apr-20 7:02 PM View: | Epizyme, Inc. (EPZM) | 31-Mar-20 | Grant | 1,512 | $15.51 | $23,451.10 | 3% 58.37K to 59.88K | (24%) |